Advisory Services Network’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5K Buy
+4,106
New +$28.1K ﹤0.01% 2919
2025
Q4
Sell
-5,106
Closed -$12.6K 2973
2025
Q3
$12.6K Buy
+5,106
New +$13.1K ﹤0.01% 3174
2024
Q1
Sell
-2,506
Closed -$12.6K 2482
2023
Q4
$12.6K Buy
+2,506
New +$7.86K ﹤0.01% 2757
2023
Q2
Sell
-800
Closed -$1.46K 2457
2023
Q1
$1.46K Sell
800
-2,400
-75% -$7.46K ﹤0.01% 3531
2022
Q4
$16.2K Buy
+3,200
New +$17.6K ﹤0.01% 2612
2022
Q2
Sell
-113,299
Closed -$636K 1431
2022
Q1
$636K Buy
+113,299
New +$695K 0.02% 807
2021
Q3
Sell
-175
Closed -$2K 2269
2021
Q2
$2K Sell
175
-78,427
-100% -$1.3M ﹤0.01% 3322
2021
Q1
$1.87M Sell
78,602
-2,007
-2% -$52K 0.07% 367
2020
Q4
$1.07M Buy
80,609
+30,069
+59% +$289K 0.04% 473
2020
Q3
$350K Buy
+50,540
New +$504K 0.02% 764

Other funds holding IBRX